Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Diabetes, Metabolic Disorders, Type 1 diabetes | Embryonic Stem Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | Salk | ![]() |
Development Candidate, Proof of Concept | |
Cancer, Sarcoma, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Muscle Injury, Skeletal/Smooth Muscle disorders | Adult or Tissue Stem Cell | Other Components, Therapeutic Approach | UCSF | ![]() |
Development Candidate, Proof of Concept | |
Skeletal/Smooth Muscle disorders | Embryonic Stem Cell, iPS Cell | Biologic, Exosomes based therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Diabetes, Metabolic Disorders, Type 1 diabetes | Embryonic Stem Cell, iPS Cell | Biologic, Therapeutic Approach | UCLA | ![]() |
Development Candidate, Proof of Concept | |
Bone or Cartilage Disease, Cartilage defect | Adult or Tissue Stem Cell | Biologic, Therapeutic Approach | The Stone Research Foundation for Sports Medicine and Arthritis | ![]() |
Development Candidate, Proof of Concept | |
Bone or Cartilage Disease, Cartilage defect, Osteoarthritis | Embryonic Stem Cell | Donor cell therapy, Other Components, Therapeutic Approach | Scripps Health | ![]() |
Development Candidate, Proof of Concept | |
Metabolic Disorders, Neurological Disorders, Sanfilippo Syndrome/MPS III | iPS Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UC Irvine | ![]() |
Development Candidate, Proof of Concept | |
Huntington's Disease, Neurological Disorders | iPS Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | UCSD | ![]() |
Development Candidate, Proof of Concept | |
Kidney Disease | Somatic Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | UCSF | ![]() |
Development Candidate, Proof of Concept | |
Blood Cancer, Cancer, Multiple Myeloma | Somatic Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCSF | ![]() |
Development Candidate, Proof of Concept | |
Multiple Sclerosis, Neurological Disorders | iPS Cell | Small molecule therapy, Therapeutic Approach | Scripps | ![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Spinal Cord Injury | iPS Cell | Other Components, Personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Heart Disease, Heart failure | Adult or Tissue Stem Cell | Biologic, Nucleic acid based therapy, Therapeutic Approach | Cedars-Sinai | ![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders | iPS Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | Navega Therapeutics | ![]() |
Development Candidate, Proof of Concept | |
Heart Disease | iPS Cell | Model system development, Specific Cell Type Derivation, Technology | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Amyotrophic Lateral Sclerosis, Neurological Disorders | Adult or Tissue Stem Cell | Donor cell therapy, Small molecule therapy, Therapeutic Approach | UCSD | ![]() |
Development Candidate, Proof of Concept | |
Cancer, Ovarian Cancer, Solid Tumors | iPS Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | UCSD | ![]() |
Development Candidate, Proof of Concept | |
Angelman Syndrome, Autism, Neurological Disorders | iPS Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | UC Davis | ![]() |
Development Candidate, Proof of Concept | |
Epidermolysis Bullosa, Skin Disease | iPS Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Heart Disease, Heart failure | iPS Cell | Biologic, Exosomes based therapy, Nucleic acid based therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Anemia, Blood Disorders | Adult or Tissue Stem Cell, iPS Cell | Small molecule therapy, Therapeutic Approach | Stanford | ![]() |
Development Candidate, Proof of Concept | |
Liver Disease, Metabolic Disorders | iPS Cell | Diagnostic Test, Technology | UCSF | ![]() |
Development Candidate, Proof of Concept | |
Brain Cancer, Cancer, Neurological Disorders, Solid Tumors | Embryonic Stem Cell | Biologic, Exosomes based therapy, Therapeutic Approach | UC Irvine | ![]() |
Development Candidate, Proof of Concept | |
Cancer, Pancreatic Cancer, Solid Tumors | Cancer Stem Cell | Small molecule therapy, Therapeutic Approach | UCSD | ![]() |
Development Candidate, Proof of Concept | |
Heart Disease | iPS Cell | Donor cell therapy, Therapeutic Approach | UC Davis | ![]() |
Development Candidate, Proof of Concept | |
Liver Disease, Metabolic Disorders | iPS Cell | Donor cell therapy, Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | CHLA | ![]() |
Development Candidate, Proof of Concept | |
iPS Cell | Defined Bioscience, Inc. | Tool/Resources/Bottleneck | ||||
HEALIOS NA, Inc. | ||||||
aa Multiple Diseases (Centers & Resoures) | Cell processing & handling, Technology | UC Davis | ![]() |
Tool/Resources/Bottleneck | ||
Other, Toxicity | iPS Cell | Model system development, Technology | Greenstone Biosciences | ![]() |
Tool/Resources/Bottleneck | |
Heart Disease | iPS Cell | Model system development, Technology | Organos, Inc. | ![]() |
Tool/Resources/Bottleneck | |
Kidney Disease, Kidney Failure | Adult or Tissue Stem Cell | Device, Technology, Therapeutic Approach, Tissue engineering | UC Davis | ![]() |
Pre-IND/IDE or Equivalent | |
Beta Thalassemia, Blood Disorders, Sickle Cell Disease | Adult or Tissue Stem Cell | Diagnostic Test, Technology | UCSF | ![]() |
Regulated Lab Test, Ready for Validation | |
Other | Adult or Tissue Stem Cell | Small molecule therapy, Therapeutic Approach | UCSF | ![]() |
Pre-IND/IDE or Equivalent | |
Ray Therapeutics, INC | ||||||
Cedars-Sinai | ||||||
Siren Biotechnology, Inc. | ||||||
UCLA | ||||||
UCSD | ||||||
UCSD | ||||||
UCLA | ||||||
Blood Cancer, Cancer, Multiple Myeloma | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | COH | ![]() |
Pre-IND/IDE or Equivalent | |
UCLA | ||||||
Corneal Damage, Vision Loss | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | ||
Neurological Disorders, Parkinson's Disease | iPS Cell | Personalized cell therapy, Therapeutic Approach | BrainXell Therapeutics | ![]() |
Pre-IND/IDE or Equivalent | |
Blood Disorders | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | ImmunoVec | ![]() |
Pre-IND/IDE or Equivalent | |
HIV/AIDS, Infectious Disease | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Corneal Damage, Vision Loss | Adult or Tissue Stem Cell | Biologic, Exosomes based therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Cancer, Lung Cancer, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | USC | ![]() |
Pre-IND/IDE or Equivalent |